2019
DOI: 10.5920/bjpharm.596
|View full text |Cite
|
Sign up to set email alerts
|

Hot-melt co-extrusion technology as a manufacturing platform for anti-hypertensive fixed-dose combinations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 1 publication
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?